Pre-IPO investing is the process of buying shares of a company before they are listed on a stock exchange. These unlisted shares allow investors to enter early, often at a relatively lower valuation, before the IPO launch.
PharmEasy is a Mumbai-based digital health-care and e-pharmacy platform launched in 2015,
offering medicines, OTC health products, diagnostics, and tele-consultation through
a unified online marketplace.
Pre-IPO investing is the process of buying shares of a company before they are listed on a stock exchange. These unlisted shares allow investors to enter early, often at a relatively lower valuation, before the IPO launch.
Early entry at valuations lower than IPO price
High return potential if the company performs well post-listing
Portfolio diversification beyond stocks, SIPs, and ETFs
Access to high-growth sectors like fintech, EV, renewable energy, and FMCG
Wealth creation - past IPOs like Zomato, DMart, and Paytm rewarded early investors
Supremus Angel bridged exclusive Pre-IPO opportunities and retail investors. We provide expert insights, ensuring informed investment decisions for maximum ROI.
Pre-IPO share valuation is based on recent funding rounds, financials, market trends, and peer comparison. We offer valuation analysis for each deal.
Returns vary, but many investors have seen 3x-10x returns in past Pre-IPO cases, depending on timing, company fundamentals, and market momentum.
Capital gains tax on Pre-IPO (unlisted) shares in India:
Short-Term (≤24 months): Taxed as per your income tax slab.
Long-Term (>24 months): Taxed at 20% with indexation.
Supremus Angel dosen't charge any brokerage or service fee rather than pre-ipo share buying prices.
Some Pre-IPO shares may have OTC exit options pre-listing. Post-IPO, shares can be sold after lock-in ends.
Once payment and documentation are done, share delivery typically happens within 24-48 hrs.
